SCHEMBL14118681

SCHEMBL14118681

O=C=NCc1cccc2cccc(CN=C=O)c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.41
GABRB2 P47870 2/20 0.41
ALDH1A1 P00352 5/20 0.36
HSD17B10 Q99714 4/20 0.36
CYP3A4 P08684 3/20 0.36
CYP1A2 P05177 3/20 0.36
TSHR P16473 3/20 0.36
HPGD P15428 3/20 0.36
CYP1A1 P04798 1/20 0.36
CYP1B1 Q16678 1/20 0.36
CES2 O00748 1/20 0.33
BCHE P06276 1/20 0.33
CES1 P23141 1/20 0.33
MCL1 Q07820 1/20 0.33
PPARG P37231 1/20 0.33
HEXA P06865 1/20 0.32
HEXB P07686 1/20 0.32
CYP2D6 P10635 1/20 0.31
CYP2C19 P33261 1/20 0.31
TYMS P04818 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29589427 1.00 GABRA1 (0.41) GABRA1GABRB2ALDH1A1HSD17B10CYP3A4
SCHEMBL1848951 0.82 CYP1A2 (0.48) ALDH1A1CYP1A2HPGDCYP2D6CYP2C19
SCHEMBL29364508 0.81 GABRA1 (0.41) GABRA1GABRB2ALDH1A1CYP3A4CYP1A2
SCHEMBL127043 0.81 GABRA1 (0.41) GABRA1GABRB2ALDH1A1CYP3A4CYP1A2
SCHEMBL1493002 0.80 GABRA1 (0.42) GABRA1GABRB2ALDH1A1CYP3A4CYP1A2
SCHEMBL3459587 0.80 GABRA1 (0.47) GABRA1GABRB2CYP3A4
SCHEMBL1225220 0.80 GABRA1 (0.42) GABRA1GABRB2CYP3A4
Benzene SCHEMBL28107745 0.79 GABRA1 (0.40) GABRA1GABRB2ALDH1A1CYP3A4CYP1A2
Water SCHEMBL5172983 0.79 GABRA1 (0.40) GABRA1GABRB2ALDH1A1CYP3A4CYP1A2
SCHEMBL28225610 0.79 GABRA1 (0.40) GABRA1GABRB2ALDH1A1CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12261265-B2 Method for producing lithium fluorosulfonate, lithium fluorosulfonate, nonaqueous electrolytic solution, and nonaqueous electrolytic solution secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2025-03-25 US disclosed
EP-3709426-B1 NONAQUEOUS ELECTROLYTE SOLUTION AND ENERGY DEVICE USING SAME MITSUBISHI CHEM CORP (JP) 2025-02-26 EP disclosed
US-20240154170-A1 NONAQUEOUS ELECTROLYTE, NONAQUEOUS ELECTROLYTE SECONDARY BATTERY, AND ENERGY DEVICE MITSUBISHI CHEMICAL CORPORATION (JP) 2024-05-09 US disclosed
EP-3584872-B1 NONAQUEOUS ELECTROLYTIC SOLUTION AND POWER STORAGE DEVICE MITSUBISHI CHEM CORP (JP) 2023-10-25 EP disclosed
EP-4219400-A2 METHOD FOR PRODUCING LITHIUM FLUOROSULFONATE, LITHIUM FLUOROSULFONATE, USE OF LITHIUM FLUOROSULFONATE IN A NONAQUEOUS ELECTROLYTIC SOLUTION, AND NONAQUEOUS ELECTROLYTIC SOLUTION Mitsubishi Chemical Corporation (JP) 2023-08-02 EP disclosed
US-11631895-B2 Nonaqueous electrolyte solution and energy device using same MITSUBISHI CHEMICAL CORPORATION (JP) 2023-04-18 US disclosed
EP-3782958-B1 NONAQUEOUS ELECTROLYTIC SOLUTION SECONDARY BATTERY MITSUBISHI CHEM CORP (JP) 2023-03-01 EP disclosed
US-20220320570-A1 METHOD FOR PRODUCING LITHIUM FLUOROSULFONATE, LITHIUM FLUOROSULFONATE, NONAQUEOUS ELECTROLYTIC SOLUTION, AND NONAQUEOUS ELECTROLYTIC SOLUTION SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2022-10-06 US disclosed
US-11387484-B2 Method for producing lithium fluorosulfonate, lithium fluorosulfonate, nonaqueous electrolytic solution, and nonaqueous electrolytic solution secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2022-07-12 US disclosed
US-11302966-B2 Amine borate compound containing nonaqueous electrolytic solution and power storage device MITSUBISHI CHEMICAL CORPORATION (JP) 2022-04-12 US disclosed
US-9515348-B2 Nonaqueous electrolytic solution and nonaqueous-electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2016-12-06 US disclosed
EP-2958181-A1 NON-AQUEOUS ELECTROLYTIC SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY Mitsubishi Chemical Corporation (JP) 2015-12-23 EP disclosed
EP-2535976-B1 NON-AQUEOUS ELECTROLYTE SOLUTION, AND SECONDARY BATTERY COMPRISING THE SAME MITSUBISHI CHEM CORP (JP) 2015-09-02 EP disclosed
EP-2863469-A1 NONAQUEOUS ELECTROLYTE SECONDARY CELL AND METHOD FOR USING SAME Mitsubishi Chemical Corporation (JP) 2015-04-22 EP disclosed
US-8673489-B2 Nonaqueous electrolytic solution and nonaqeuous-electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2014-03-18 US disclosed
EP-2698350-A1 METHOD FOR PRODUCING LITHIUM FLUOROSULFONATE, LITHIUM FLUOROSULFONATE, NONAQUEOUS ELECTROLYTE SOLUTION, AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY Mitsubishi Chemical Corporation (JP) 2014-02-19 EP disclosed
US-20140038062-A1 METHOD FOR PRODUCING LITHIUM FLUOROSULFONATE, LITHIUM FLUOROSULFONATE, NONAQUEOUS ELECTROLYTIC SOLUTION, AND NONAQUEOUS ELECTROLYTIC SOLUTION SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2014-02-06 US disclosed
US-20130280622-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2013-10-24 US disclosed
EP-2535976-A1 NONAQUEOUS ELECTROLYTE SOLUTION, AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY Mitsubishi Chemical Corporation (JP) 2012-12-19 EP disclosed
US-20120308881-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQEUOUS-ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2012-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11631895-B2 Nonaqueous electrolyte solution and energy device using same SLC26A3, VDAC3, SLC25A13 GABRA1 3076/4885GABRB2 3739/4885ALDH1A1 2342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.